- Home
- ACXP vs ZDAI Comparison
ACXP vs ZDAI Comparison
Compare ACXP & ZDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACXP | ZDAI |
|---|---|---|
| Founded | 2017 | 2022 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | General Bldg Contractors - Nonresidential Bldgs |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 6.3M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | ACXP | ZDAI |
|---|---|---|
| Price | $2.84 | $0.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $143.67 | N/A |
| AVG Volume (30 Days) | 56.0K | ★ 307.3K |
| Earning Date | 11-12-2025 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $15,141,479.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.44 | $0.20 |
| 52 Week High | $21.00 | $1.17 |
Technical Indicators
Market Signals| Indicator | ACXP | ZDAI |
|---|---|---|
| Relative Strength Index (RSI) | 40.77 | 64.57 |
| Support Level | $2.51 | $0.42 |
| Resistance Level | $2.85 | $0.65 |
| Average True Range (ATR) | 0.19 | 0.08 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 24.27 | 82.37 |
Price Performance
Historical ComparisonAbout ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About ZDAI Primega Group Holdings Limited Ordinary Shares
DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.